[Federal Register Volume 72, Number 70 (Thursday, April 12, 2007)]
[Notices]
[Pages 18482-18483]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E7-6927]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Implementing Surveillance to Determine the 
Prevalence of the Autism Spectrum Disorders and Other Developmental 
Disabilities in Early Childhood Populations, Request for Applications 
(RFA) DD 07-007

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting.
    Time and Date: 12 p.m.-3 p.m., June 7, 2007 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance with 
provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., 
and the Determination of the Director, Management Analysis and Services 
Office, CDC, pursuant to Public Law 92-463.
    Matters To Be Discussed: The meeting will include the review, 
discussion, and evaluation of ``Implementing

[[Page 18483]]

Surveillance to Determine the Prevalence of the Autism Spectrum 
Disorders and Other Developmental Disabilities in Early Childhood 
Populations,'' RFA DD 07-007.
    For Further Information Contact: Sheree Williams, PhD, Scientific 
Review Administrator, Office of the Chief Science Officer, CDC, 1600 
Clifton Road NE., Mailstop D 72, Atlanta, GA 30333, Telephone 404-639-
4896.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both CDC and the Agency for Toxic Substances and Disease Registry.

    Dated: April 5, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
 [FR Doc. E7-6927 Filed 4-11-07; 8:45 am]
BILLING CODE 4163-18-P